M. Denton

发表

Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic

M. Denton, J. Littlewood, K. Brownlee, 1996 .

Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital.

J. Heritage, P. Hawkey, D. Gascoyne-Binzi, 1997, The Journal of antimicrobial chemotherapy.

A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis

L. Fletcher, C. Beggs, M. Denton, 2008, BMC Microbiology.

Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis.

K. Kerr, M. Denton, D. Peckham, 2003, The Journal of hospital infection.

Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center

M. Denton, S. Conway, K. Brownlee, 2004, Pediatric pulmonology.

Antibiotic Prescribing in Critical Care: Specific Indications

M. Denton, N. Watson, 2008 .

Survival of Mycobacterium abscessus isolated from people with cystic fibrosis in artificially generated aerosols

L. Fletcher, M. Denton, I. Clifton, 2016, European Respiratory Journal.

Mycobacterium abscessus in people with cystic fibrosis: considerations for psychosocial care.

M. Denton, A. Duff, V. Shearing, 2015, The Lancet. Respiratory medicine.

PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients

Samuel I. Miller, N. Høiby, S. Moskowitz, 2011, Antimicrobial Agents and Chemotherapy.

A five year outbreak of methicillin-susceptible Staphylococcus aureus phage type 53,85 in a regional neonatal unit

M. Wilcox, P. Hawkey, P. Parnell, 2000, Epidemiology and Infection.

Correlation between genotype and beta-lactamases of clinical and environmental strains of Stenotrophomonas maltophilia.

P. Hawkey, M. Denton, V. Keer, 1999, The Journal of antimicrobial chemotherapy.

Brief reports Correlation between genotype and -lactamases of clinical and environmental strains of Stenotrophomonas maltophilia

P. Hawkey, M. Denton, V. Keer, 1999 .

The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland.

V. Jarlier, M. Denton, B. O'Connell, 2008, The Journal of antimicrobial chemotherapy.

A critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with cystic fibrosis for application in clinical trials.

B. Tümmler, P. Dřevínek, E. Nash, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Optimizing treatment policies and improving care: impact on outcome in patients with cystic fibrosis

M. Denton, D. Peckham, S. Conway, 2005, Expert review of pharmacoeconomics & outcomes research.

Clinical practice guidelines: a tool to help provide quality care.

M. Denton, J. Borenstein, S. Deutsch, 1998, Geriatrics.

Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis

P. Simmonds, H. Harvala, M. Denton, 2015, European Respiratory Journal.

Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

M. Denton, S. Conway, K. Brownlee, 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis.

D. Saralaya, M. Denton, D. Peckham, 2004, The Journal of antimicrobial chemotherapy.

Population-level genomics identifies the emergence and global spread of a human transmissible multidrug-resistant nontuberculous mycobacterium

Judith, Terese, L. Morawska, 2016 .

Decision Making about Risk of Infection by Young Adults with CF

G. Latchford, M. Denton, D. Peckham, 2013, Pulmonary medicine.

Antibiotic Prescribing in Critical Care: General Principles

M. Denton, N. Watson, 2007 .

Antibiotic prescribing in critical care: general principles Antibiotic prescribing in critical care: general principles

M. Denton, N. Watson, 2007 .

Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis

M. Denton, D. Peckham, S. Conway, 2003, American journal of respiratory medicine : drugs, devices, and other interventions.

Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia

K. Kerr, M. Denton, 1998, Clinical Microbiology Reviews.

Ten years of viral and non-bacterial serology in adults with cystic fibrosis

J. Kastelik, M. Denton, I. Clifton, 2007, Epidemiology and Infection.

eff ects, identifying distress, and providing appropriate treatment are important factors to address.

M. Denton, A. Duff, V. Shearing, 2015 .

Transmission of colistin‐resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center

K. Kerr, M. Denton, K. Brownlee, 2002, Pediatric pulmonology.

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation.

M. Denton, D. Peckham, S. Conway, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series

M. Denton, I. Clifton, D. Peckham, 2019, The Journal of antimicrobial chemotherapy.

Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.

M. Denton, D. Peckham, S. Conway, 2007, The Journal of antimicrobial chemotherapy.

Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis.

M. Denton, S. Conway, K. Nadesalingam, 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Effectiveness of deep cleaning followed by hydrogen peroxide decontamination during high Clostridium difficile infection incidence.

M. Copland, M. Wilcox, R. Hobson, 2014, The Journal of hospital infection.

Methicillin-resistant Staphylococcus aureus.

M. Denton, K. Brownlee, E. Turner, 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus.

M. Kerr, R. Barton, R. Hobson, 2008, Diagnostic microbiology and infectious disease.

A/H1N1 and other viruses affecting cystic fibrosis

M. Denton, D. Peckham, S. Conway, 2009, BMJ : British Medical Journal.

Surveillance of antibiotic susceptibility of Enterobacteriaceae isolated from urine samples collected from community patients in a large metropolitan area, 2010–2012

M. Wilcox, N. Abberley, C. Horner, 2013, Epidemiology and Infection.

Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France—joint authors' response

V. Jarlier, R. Skov, M. Denton, 2008 .

Co-existent cross-infection with Streptococcus pneumoniae and group B streptococci on an adult oncology unit.

P. Hawkey, M. Denton, C. Hoy, 1993, The Journal of hospital infection.

The UK Cystic Fibrosis Trust Infection Control Working Group

J. Govan, M. Denton, D. Heaf, 2008 .

Circulation of a community healthcare-associated multiply-resistant meticillin-resistant Staphylococcus aureus lineage in South Yorkshire identified by whole genome sequencing.

A. Kearns, G. Hughes, B. Pichon, 2019, The Journal of hospital infection.

Serum tobramycin levels following delivery of tobramycin (Tobi) via eFlow advanced nebuliser in children with cystic fibrosis.

M. Denton, S. Conway, K. Brownlee, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Short Communication Serum tobramycin levels following delivery of tobramycin (Tobi®) via eFlow® advanced nebuliser in children with cystic fibrosis ☆

M. Denton, M. Bosomworth, E. Guy, 2010 .

Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.

M. Denton, S. Conway, K. Brownlee, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis.

L. Fletcher, C. Beggs, M. Denton, 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

L. Morawska, L. Knibbs, H. Rodgers, 2016, Science.

Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients.

M. Wilcox, M. Denton, 1997, The Journal of antimicrobial chemotherapy.

Isolation of the Fungus Geosmithia argillacea in Sputum of People with Cystic Fibrosis

J. Houbraken, R. Barton, R. Hobson, 2010, Journal of Clinical Microbiology.

Clostridium botulinum: an increasing complication of heroin misuse

J. Cooper, M. Denton, S. Jamieson, 2005, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Fungal contamination of nebuliser devices used by people with cystic fibrosis.

R. Barton, M. Denton, D. Peckham, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Faucet aerators: a source of patient colonization with Stenotrophomonas maltophilia.

K. Kerr, M. Denton, L. Mooney, 2000, American journal of infection control.

Role of anti-pseudomonal antibiotics in the emergence ofStenotrophomonas maltophilia in cystic fibrosis patients

M. Denton, J. Littlewood, N. Todd, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

A new selective differential medium for isolation ofStenotrophomonas maltophilia

P. Hawkey, K. Kerr, M. Denton, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Stenotrophomonas maltophilia in Salad

K. Kerr, M. Denton, A. Qureshi, 2005, Emerging infectious diseases.

Survival and Growth of Burkholderia cepacia Within the Free-Living Amoeba Acanthamoeba polyphaga

E. Ingham, J. Tipper, K. Kerr, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Acute bronchopulmonary infection due toStreptococcus milleri in a child with cystic fibrosis

M. Denton, K. Brownlee, N. Todd, 1999, Archives of disease in childhood.

Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12).

M. Wilcox, W. Fawley, P. Parnell, 2014, The Journal of antimicrobial chemotherapy.

Caution against the use of monotherapy in neutropenic patients.

M. Denton, N. Todd, D. Birkenhead, 1991, The Journal of infectious diseases.

Staphylococcus aureus and MRSA

M. Denton, S. Conway, 2006 .

Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium.

K. Kerr, M. Denton, J. Littlewood, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Molecular Epidemiology of Stenotrophomonas maltophilia Isolated from Clinical Specimens from Patients with Cystic Fibrosis and Associated Environmental Samples

P. Hawkey, K. Kerr, M. Denton, 1998, Journal of Clinical Microbiology.

Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit.

M. Wilcox, P. Hawkey, P. Parnell, 2005, Intensive & critical care nursing.

Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients.

K. Kerr, M. Denton, L. Mooney, 2001, International journal of antimicrobial agents.

Corynebacterium striatum endocarditis masquerading as connective tissue disorders.

J. Sandoe, M. Denton, B. Stoddart, 2005, Rheumatology.

Bloodstream infections in cystic fibrosis: nine years of experience in both adults and children.

J. Cargill, M. Denton, D. Peckham, 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Epidemiology and microbiological characterization of clinical isolates of Staphylococcus aureus in a single healthcare region of the UK, 2015

C. Horner, M. Denton, L. Utsi, 2016, Epidemiology and Infection.

Case report Acute Burkholderia cenocepacia pyomyositis in a patient with cystic fibrosis

M. Denton, D. Peckham, P. Whitaker, 2009 .

Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre.

M. Denton, I. Clifton, D. Peckham, 2018, Pulmonary pharmacology & therapeutics.

Adherence to infection prevention and control guidelines: A vignette-based study of decision-making and risk-taking in young adults with cystic fibrosis.

G. Latchford, M. Denton, A. Duff, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resection.

H. Malik, M. Wilcox, M. Denton, 2009, Annals of the Royal College of Surgeons of England.

Water filters can prevent Stenotrophomonas maltophilia contamination of nebuliser equipment used by people with cystic fibrosis.

M. Denton, D. Peckham, S. Conway, 2008, The Journal of hospital infection.

Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit.

M. Wilcox, P. Hawkey, P. Parnell, 2004, The Journal of hospital infection.

Molecular Epidemiology of Stenotrophomonas maltophilia Isolated from Cystic Fibrosis Patients

K. Kerr, M. Denton, 2002, Journal of Clinical Microbiology.

Stenotrophomonas maltophilia bacteraemia in two patients with cystic fibrosis associated with totally implantable venous access devices.

K. Kerr, M. Denton, D. Peckham, 2002, The Journal of infection.

Short communication Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients

M. Denton, L. Mooney, 2001 .

Stenotrophomonas maltophilia: an emerging problem in cystic fibrosis patients

M. Denton, 1997 .

Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?

M. Denton, S. Conway, K. Brownlee, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

'Cepacia syndrome' with Burkholderia multivorans, 9 years after initial colonization.

M. Denton, K. Brownlee, S. Conway, 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

The Effect of Sub-MIC β-Lactam Antibiotic Exposure of Pseudomonas aeruginosa Strains from People with Cystic Fibrosis in a Desiccation Survival Model

M. Denton, I. Clifton, D. Peckham, 2011, International journal of microbiology.

Acute Burkholderia cenocepacia pyomyositis in a patient with cystic fibrosis.

M. Denton, I. Clifton, D. Peckham, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?

M. Denton, D. Peckham, S. Conway, 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Corrigendum to “Enterobacteriaceae” [Int. J. Antimicrob. Agents 29 (2007) S9–S22]

M. Denton, 2007 .

Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia

K. Kerr, M. Denton, 1998, Clinical Microbiology Reviews.

Molecular Epidemiology of Stenotrophomonas maltophilia Isolated from Clinical Specimens from Patients with Cystic Fibrosis and Associated Environmental Samples

P. Hawkey, K. Kerr, M. Denton, 1998, Journal of Clinical Microbiology.

Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales

N. Woodford, C. Ison, M. David, 2016, Sexually Transmitted Infections.

Error bars represent standard error of mean

L. Fletcher, C. Beggs, M. Denton, 2011 .

A protracted outbreak of difficult-to-treat resistant Pseudomonas aeruginosa in a haematology unit: a matched case-control study demonstrating increased risk with fluoroquinolone use.

William Q. Rice, M. Denton, A. Barrasa, 2022, The Journal of hospital infection.